Phase I/II trial of oral EPI-7386 in combination with enzalutamide (enz) compared to enz alone in metastatic castration-resistant prostate cancer (mCRPC) subjects: Current phase I (PI) results Meeting Abstract
| Authors: | Laccetti, A. L.; Chatta, G.; Kyriakopoulos, C.; Iannotti, N.; Hotte, S. J.; Markowski, M. C.; Pili, R.; Vuky, J.; Zhang, J.; Saad, F.; Villaluna, K.; Younginger, B.; Le Moigne, R.; Cesano, A. |
| Abstract Title: | Phase I/II trial of oral EPI-7386 in combination with enzalutamide (enz) compared to enz alone in metastatic castration-resistant prostate cancer (mCRPC) subjects: Current phase I (PI) results |
| Meeting Title: | ESMO Congress 2023 |
| Journal Title: | Annals of Oncology |
| Volume: | 34 |
| Issue: | Suppl. 2 |
| Meeting Dates: | 2023 Oct 20-24 |
| Meeting Location: | Madrid, Spain |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2023-10-01 |
| Start Page: | S982 |
| End Page: | S983 |
| Language: | English |
| ACCESSION: | WOS:001087480202481 |
| DOI: | 10.1016/j.annonc.2023.09.2761 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 1813P -- Source: Wos |
